How should prominent adnexal vessels seen on MRI be managed?

Management of Prominent Adnexal Vessels on MRI

Prominent adnexal vessels seen on MRI without an associated mass are typically a normal anatomic variant and require no further action or follow-up. The key is determining whether these vessels are isolated findings or associated with an actual adnexal mass.

Clinical Decision Algorithm

Step 1: Confirm No Associated Mass

• Review the MRI systematically to ensure the prominent vessels are not associated with a solid or complex adnexal lesion
• If vessels are isolated without any mass, cyst, or structural abnormality → no further imaging or intervention needed
• Prominent ovarian vessels alone do not indicate pathology

Step 2: If an Associated Mass is Present

The management pathway depends entirely on mass characteristics, not vessel prominence:

For indeterminate masses on initial ultrasound:

• MRI pelvis with and without IV contrast is the appropriate next step 1
• Contrast enhancement is critical because it identifies enhancing solid tissue components that drive malignancy risk assessment 1
• The presence or absence of enhancing solid tissue and enhancement curve characteristics determine malignancy risk 1

For masses suspicious for malignancy on ultrasound:

• Proceed with transvaginal ultrasound with Doppler as the primary follow-up modality 1
• Color or power Doppler evaluates vascularity of solid components 1
• Solid components with increased color or spectral Doppler flow are concerning for malignancy 1

Step 3: Risk Stratification Using O-RADS MRI

If a mass is present, apply the O-RADS MRI scoring system 2, 3:

• Score 2 (benign): 96.4% accuracy for benign diagnosis 1
• Score 4 (intermediate risk): 5-90% malignancy prevalence - requires careful assessment 4
• Score 5 (high risk): Refer for oncologic surgical evaluation 2

Key Imaging Features That Matter

Vessels are NOT a primary risk factor. Focus instead on:

• Solid tissue characteristics: Size, T2 signal intensity, diffusion restriction, and enhancement pattern 1, 4
• Enhancement kinetics: Type 3 curves (rapid enhancement greater than myometrium) indicate invasive malignancy with 67% sensitivity 1
• Papillary projections: >4 papillary structures with blood flow are concerning 1
• Solid tissue size: Larger solid components correlate with malignancy 4

Common Pitfalls to Avoid

1. Do not confuse prominent vessels with solid tissue - Use contrast-enhanced sequences to distinguish vascular structures from true solid components 1

2. Do not order unnecessary follow-up for isolated vessel prominence - This is a normal variant and does not require surveillance

3. Do not use non-contrast MRI when contrast is feasible - Contrast-enhanced MRI performs superiorly to non-contrast MRI for detecting enhancing soft tissue components 1

4. Do not rely on CT for adnexal mass characterization - CT is not useful for further characterization of indeterminate adnexal lesions 1

When Contrast Cannot Be Used

If IV contrast is contraindicated and a mass is present:

• Non-contrast MRI with diffusion-weighted imaging (DWI) can be used 1
• Sensitivity 85%, specificity 96%, accuracy 94.2% for cancer detection 1
• Morphologic assessment combined with DWI provides 84.9% sensitivity and 95.9% specificity 1

Bottom line: Prominent adnexal vessels alone are benign and require no action. Management decisions are driven by the presence and characteristics of an associated mass, not vessel prominence.